Pascal Schneider
AstraZeneca (Sweden) · 360 works · 42,854 citations · h-index 93
Top works
- Inhibition of death receptor signals by cellular FLIP
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule
- Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
- Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
- BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
- Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
- TRAMP, a Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95)
- MyD88, an Adapter Protein Involved in Interleukin-1 Signaling
- Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity
- BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF
- APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
- TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
- IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
- Baff Mediates Survival of Peripheral Immature B Lymphocytes
- Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
- BAFF and APRIL: A Tutorial on B Cell Survival
- TRAIL receptor-2 signals apoptosis through FADD and caspase-8
- Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
- Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population